---
ver: rpa2
title: Adaptive Federated Few-Shot Rare-Disease Diagnosis with Energy-Aware Secure
  Aggregation
arxiv_id: '2510.00976'
source_url: https://arxiv.org/abs/2510.00976
tags:
- federated
- privacy
- few-shot
- aggregation
- were
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: 'This paper addresses rare-disease diagnosis in federated learning
  settings, where data scarcity, privacy concerns, and limited device resources hinder
  performance. The proposed Adaptive Federated Few-Shot Rare-Disease Diagnosis (AFFR)
  framework integrates three components: few-shot federated optimization with meta-learning
  for generalization from limited samples, energy-aware client scheduling to reduce
  dropouts, and secure aggregation with calibrated differential privacy to protect
  model updates.'
---

# Adaptive Federated Few-Shot Rare-Disease Diagnosis with Energy-Aware Secure Aggregation

## Quick Facts
- **arXiv ID:** 2510.00976
- **Source URL:** https://arxiv.org/abs/2510.00976
- **Reference count:** 14
- **Primary result:** Proposed framework improves federated rare-disease diagnosis accuracy by up to 10% and reduces client dropouts by over 50% while maintaining clinically acceptable privacy-utility trade-offs.

## Executive Summary
This paper introduces AFFR, a federated learning framework designed to diagnose rare diseases in resource-constrained, privacy-sensitive healthcare environments. The method combines few-shot federated optimization with meta-learning to generalize from limited samples, energy-aware client scheduling to reduce dropouts, and secure aggregation with calibrated differential privacy to protect model updates. Evaluation on simulated and real clinical rare-disease datasets demonstrates significant improvements over baseline federated learning, with accuracy gains of up to 10% and dropout reductions exceeding 50%. The work addresses critical gaps in privacy preservation, energy efficiency, and performance in federated rare-disease diagnosis.

## Method Summary
AFFR integrates three core components to address federated rare-disease diagnosis challenges. First, few-shot federated optimization with meta-learning enables effective learning from limited samples by leveraging knowledge transfer across tasks. Second, energy-aware client scheduling dynamically selects participating devices based on their energy levels, minimizing dropouts and ensuring continuous model training. Third, secure aggregation with calibrated differential privacy adds Gaussian noise to model updates, protecting patient data while maintaining utility. The framework was evaluated using both simulated and real clinical rare-disease datasets, demonstrating robust performance across diverse scenarios.

## Key Results
- **Accuracy Improvement:** AFFR achieves up to 10% higher accuracy than baseline federated learning methods for rare-disease diagnosis.
- **Dropout Reduction:** Energy-aware client scheduling reduces client dropouts by over 50%, improving model convergence and stability.
- **Privacy Preservation:** Secure aggregation with calibrated differential privacy maintains clinically acceptable privacy-utility trade-offs.

## Why This Works (Mechanism)
The AFFR framework succeeds by addressing the core challenges of federated rare-disease diagnosis: data scarcity, privacy concerns, and limited device resources. Few-shot federated optimization with meta-learning enables effective learning from small sample sizes by transferring knowledge across tasks. Energy-aware client scheduling ensures stable participation by selecting devices with sufficient energy, reducing dropouts and maintaining convergence. Secure aggregation with calibrated differential privacy protects patient data during model updates, balancing utility and privacy. Together, these components create a practical, equitable, and privacy-preserving solution for distributed healthcare environments.

## Foundational Learning
- **Federated Learning:** Decentralized training across multiple devices without sharing raw data; needed to preserve privacy in healthcare.
- **Few-Shot Learning:** Learning from limited examples by leveraging prior knowledge; essential for rare-disease diagnosis where data is scarce.
- **Meta-Learning:** Training models to quickly adapt to new tasks with minimal data; improves generalization in few-shot scenarios.
- **Differential Privacy:** Adding noise to protect individual data points; required for regulatory compliance and patient trust.
- **Energy-Aware Scheduling:** Dynamically selecting devices based on resource availability; reduces dropouts and maintains convergence.
- **Secure Aggregation:** Cryptographic techniques to aggregate model updates without exposing individual contributions; ensures privacy during training.

## Architecture Onboarding
- **Component Map:** Meta-learning (Few-Shot FL) -> Energy-Aware Client Scheduling -> Secure Aggregation (DP) -> Model Update
- **Critical Path:** Client selection (energy-aware) → Local training (few-shot meta-learning) → Secure aggregation (DP noise) → Global model update
- **Design Tradeoffs:** Lightweight models (LR/MLP) for energy efficiency vs. potential accuracy gains from deeper architectures; approximated DP for simplicity vs. rigorous privacy guarantees.
- **Failure Signatures:** High client dropout rates indicate energy constraints or network instability; privacy budget exhaustion suggests overly strict DP settings; convergence failure may point to insufficient few-shot adaptation.
- **First Experiments:** 1) Evaluate energy-aware scheduling under varying device constraints; 2) Test few-shot meta-learning with different base models; 3) Measure privacy-utility trade-offs under formal DP accounting.

## Open Questions the Paper Calls Out
### Open Question 1
- **Question:** Can the AFFR framework maintain its convergence benefits and accuracy when applied to deep medical imaging architectures?
- **Basis in paper:** [explicit] The authors state in the Limitations and Future Work sections that "only shallow learners (LR and MLP) were implemented," and benchmarking against "deep medical imaging models" is deferred to future work.
- **Why unresolved:** Deep neural networks have significantly higher computational and memory demands than the lightweight models tested, potentially exacerbating energy constraints and altering convergence dynamics.
- **What evidence would resolve it:** Evaluation of AFFR using convolutional neural networks (CNNs) or transformers on high-dimensional clinical datasets.

### Open Question 2
- **Question:** Does the inclusion of formal differential privacy accounting ($\epsilon, \delta$ guarantees) negate the reported utility improvements?
- **Basis in paper:** [explicit] The paper acknowledges that differential privacy was "approximated via Gaussian noise without rigorous $(\epsilon, \delta)$ accounting," listing formal accounting as a future work item.
- **Why unresolved:** The current implementation serves as a "didactic knob" rather than a certified privacy mechanism; formal clipping and accounting often impose stricter utility penalties than simple noise injection.
- **What evidence would resolve it:** Integration of a moments accountant or Rényi differential privacy mechanism demonstrating privacy bounds with comparable accuracy.

### Open Question 3
- **Question:** Is the proposed modular pipeline effective under the extreme statistical and system heterogeneity of production hospital environments?
- **Basis in paper:** [explicit] The authors note evaluation was "limited to simulated datasets and a small pilot cohort" and list "deployment on real-world rare-disease cohorts" as a necessary extension.
- **Why unresolved:** Simulated environments may not fully capture the "wild" variability of network stability, label noise, and non-IID data distributions found in actual clinical networks.
- **What evidence would resolve it:** Results from a live pilot across distinct clinical sites with uncurated electronic health records.

## Limitations
- Evaluation limited to shallow models (LR, MLP) without testing deep medical imaging architectures.
- Differential privacy implementation lacks formal $(\epsilon, \delta)$ accounting, raising questions about actual privacy guarantees.
- Results based on simulated and small pilot datasets; real-world heterogeneity and scalability remain untested.

## Confidence
- **Technical feasibility:** High
- **Performance improvements:** Medium
- **Privacy guarantees:** Low

## Next Checks
1. Test the framework on a broader range of real-world clinical datasets with varying sizes, distributions, and device heterogeneity to assess generalizability and scalability.
2. Conduct adversarial privacy analysis, including membership inference and reconstruction attacks, to quantify actual privacy leakage under the proposed differential privacy calibration.
3. Perform a controlled clinical study to validate whether the claimed accuracy improvements translate into clinically meaningful diagnostic outcomes and acceptable false-positive/negative rates.